<DOC>
	<DOCNO>NCT02403531</DOCNO>
	<brief_summary>The contribution induction chemotherapy definitive chemoradiotherapy unknown . The purpose study compare efficacy toxicity induction chemotherapy follow definitive chemoradiotherapy versus induction chemotherapy patient inoperable thoracic esophageal squamous cell carcinoma .</brief_summary>
	<brief_title>Induction Chemotherapy Followed Chemoradiotherapy Esophageal Cancer</brief_title>
	<detailed_description>108 patient randomized receive induction chemotherapy ( IC , Arm A ) IC ( Arm B ) definitive chemoradiotherapy patient inoperable thoracic esophageal squamous cell carcinoma . Patients assign Arm B first receive two cycle 3-weekly schedule IC , consist docetaxel 75 mg/m2 day 1 cisplatin 75 mg/m2 day 1 . The prescribed dose radiotherapy generally 50-60 Gy/25-28fr . The concomitant chemotherapy docetaxel 20 mg/m2 day 1 , cisplatin 25 mg/m2 day 1 , repeat weekly radiation .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Histologically confirm squamous cell carcinoma esophagus ; 2 . Localized , nonmetastatic disease ( T14 , N01 ) confirm endoscopic ultrasound ( EUS ) CT scan ( accord UICC TNM version 6 ) ; 3 . Absence distant metastasis solid organ ; 4 . Not suitable surgery ( either medical reason patient 's choice ) ; 5 . Age diagnosis 18 70 year ; 6 . Eastern Cooperative Oncology Group performance status ≤ 2 7 . No prior cancer therapy ; 8 . No history concomitant previous malignancy ; 9 . Hematologic function : WBC ≥ 4.0×109/L , PLT ≥ 80×109/L , Hb ≥ 10mg/dL ; 10 . Renal function : Cr ≤ 1.25×UNL ; 11 . Hepatic function : BIL ≤ 1.5×UNL , ALT/AST ≤ 2.5×UNL ; 12 . Documented informed consent participate trial . 1 . Younger 18 old 70 year age ; 2 . ECOG performance status 3 ; 3 . Other cancer history ; 4 . Previous radiotherapy history ; 5 . Subjects distant metastasis ; 6 . Pregnancy breast feed . Women childbearing age must use effective contraception ; 7 . Serious cardiovascular disease ( congestive heart failure , uncontrollable arrhythmia , unstable angina , myocardial infarction , serious heart valve disease , resistant hypertension ) ; 8 . Evidence bleed diathesis serious infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Esophageal cancer</keyword>
	<keyword>Chemoradiotherapy</keyword>
	<keyword>induction chemotherapy</keyword>
</DOC>